Zenas BioPharma, Inc. (ZBIO)
NASDAQ·Healthcare·Biotechnology
$31.25
+0.13%
Mkt Cap $1.98B
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (7 analysts)
$22.00
Range $22.00 – $22.00
Implied Upside
-29.6%
Consensus $22.00 vs current $31.25
NASDAQ·Healthcare·Biotechnology
$31.25
+0.13%
Mkt Cap $1.98B
Buy
5
Hold
2
Sell
0
Price Target (7 analysts)
$22.00
Range $22.00 – $22.00
-29.6%
Consensus $22.00 vs current $31.25